Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Qingying Zhongyao (Fuzheng Qingying Decoction) is a Traditional Chinese Medicine (TCM) formula specifically developed for the treatment of autoimmune thyroid diseases, particularly Hashimoto's thyroiditis and thyroid nodules. The formula is constructed based on the TCM principles of "Fuzheng" (strengthening the body's vital energy/resistance) and "Qingying" (clearing and resolving goiter or nodules). It typically comprises a complex mixture of herbal ingredients, including *Astragalus membranaceus* (Huangqi), *Prunella vulgaris* (Xiakucao), *Fritillaria thunbergii* (Zhebeimu), and *Scrophularia ningpoensis* (Xuanshen). The therapeutic mechanism involves immunomodulation, specifically the reduction of thyroid autoantibodies such as thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TGAb), as well as the regulation of pro-inflammatory cytokines like TNF-alpha and IL-6. Clinical studies in China have demonstrated its efficacy in reducing thyroid volume, improving clinical symptoms, and stabilizing thyroid function in patients with chronic lymphocytic thyroiditis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuzheng qingying decoction.